Abstract
OBJECTIVES: A nerve agent sarin (isopropyl methyl phosphonofluoridate) was released in Matsumoto city, Japan, on 27 June 1994. About 600 people were affected by the sarin, including seven who died. Fifty two rescuers engaged in helping the victims and 18 were affected. The aim was to investigate how the rescuers were affected by sarin. METHODS: Health examinations and a questionnaire survey were conducted with all rescuers. RESULTS: A rescuer who was one of the first engaged and who worked for about five hours in areas contaminated with sarin was admitted to hospital after poisoning; the others did not consult doctors although they showed slight muscarinic symptoms. The later the rescuers started their work, the less likely they were to experience symptoms of sarin exposure, and no one starting work 270 minutes after the original release of sarin was affected. The symptoms of exposure included ocular pain, darkness of visual field, nausea, vomiting, headache, rhinorrhea, narrowing of visual field, sore throat, fatigue, and dyspnoea, which were similar to those reported by the citizens who were sarin victims. There were no rescuers who had abnormal physical or neurological signs associated with sarin at the time of the physical examination conducted three weeks after the sarin release. A year after the sarin incident, the symptoms of all the rescuers had resolved. CONCLUSIONS: Rescuers should protect themselves with appropriate clothing, gloves, and a mask to prevent a secondary disaster for at least 24 hours after a similar accident.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dunn M. A., Sidell F. R. Progress in medical defense against nerve agents. JAMA. 1989 Aug 4;262(5):649–652. [PubMed] [Google Scholar]
- GROB D., HARVEY A. M. The effects and treatment of nerve gas poisoning. Am J Med. 1953 Jan;14(1):52–63. doi: 10.1016/0002-9343(53)90358-1. [DOI] [PubMed] [Google Scholar]
- GROB D., HARVEY J. C. Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J Clin Invest. 1958 Mar;37(3):350–368. doi: 10.1172/JCI103615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gunderson C. H., Lehmann C. R., Sidell F. R., Jabbari B. Nerve agents: a review. Neurology. 1992 May;42(5):946–950. doi: 10.1212/wnl.42.5.946. [DOI] [PubMed] [Google Scholar]
- Morita H., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., Nohara M., Midorikawa Y., Mimura S. Sarin poisoning in Matsumoto, Japan. Lancet. 1995 Jul 29;346(8970):290–293. doi: 10.1016/s0140-6736(95)92170-2. [DOI] [PubMed] [Google Scholar]
- Rengstorff R. H. Accidental exposure to sarin: vision effects. Arch Toxicol. 1985 Jan;56(3):201–203. doi: 10.1007/BF00333427. [DOI] [PubMed] [Google Scholar]
- Sidell F. R., Borak J. Chemical warfare agents: II. Nerve agents. Ann Emerg Med. 1992 Jul;21(7):865–871. doi: 10.1016/s0196-0644(05)81036-4. [DOI] [PubMed] [Google Scholar]
- Suzuki T., Morita H., Ono K., Maekawa K., Nagai R., Yazaki Y. Sarin poisoning in Tokyo subway. Lancet. 1995 Apr 15;345(8955):980–980. [PubMed] [Google Scholar]